GlaxoSmithKline (GSK) Q3 EPS Falls to 22.6p; Revs Lower Y/Y

GlaxoSmithKline (NYSE: GSK) reported Q3 EPS of 22.6 pence, versus 27.2 pence reported last year. Revenue for the quarter came in at GBP6.53 billion, versus GBP7.1 billion reported last year.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
• Middleby board approves spin-off of food processing unit Midera